Rochal Industries Overview
- Year Founded
-
1986
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
1
Rochal Industries General Information
Description
Operator of a research-oriented company focused on wound and skincare. The company offers transformative products for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic tissue debridement, cell compatible substrates and transdermal drug delivery, providing products from concept to preclinical and clinical development while meeting quality and regulatory requirements.
Contact Information
Website
www.rochalindustries.com(Operating Subsidiary)
Corporate Office
- 12000 Network Boulevard
- B-200
- San Antonio, TX 78249
- United States
Corporate Office
- 12000 Network Boulevard
- B-200
- San Antonio, TX 78249
- United States
Rochal Industries Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rochal Industries Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Rochal Industries Patents
Rochal Industries Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210121575-A1 | Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions | Active | 28-Oct-2019 | ||
| US-12090205-B2 | Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions | Active | 28-Oct-2019 | ||
| ES-2866100-T3 | Composition and kits for the inhibition of a pathogenic microbial infection and procedures for using the same | Active | 01-Oct-2014 | ||
| EP-3220741-A4 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | Active | 01-Oct-2014 | ||
| EP-3220741-A1 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | Active | 01-Oct-2014 | A61K31/785 |
Rochal Industries Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Rochal Industries Investments (1)
Rochal Industries’s most recent deal was a Joint Venture with Atteris Healthcare. The deal was made on 01-Jan-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Atteris Healthcare | 01-Jan-2016 | Joint Venture | Distributors (Healthcare) |
Rochal Industries Exits (1)
Rochal Industries’s most recent exit was on 01-Jan-2016 from Atteris Healthcare. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Atteris Healthcare | 01-Jan-2016 | Completed |
|
Rochal Industries FAQs
-
When was Rochal Industries founded?
Rochal Industries was founded in 1986.
-
Where is Rochal Industries headquartered?
Rochal Industries is headquartered in San Antonio, TX.
-
What industry is Rochal Industries in?
Rochal Industries’s primary industry is Drug Delivery.
-
Is Rochal Industries a private or public company?
Rochal Industries is a Private company.
-
What is the current valuation of Rochal Industries?
The current valuation of Rochal Industries is .
-
What is Rochal Industries’s current revenue?
The current revenue for Rochal Industries is .
-
Who are Rochal Industries’s investors?
The Catalyst Group (Houston) has invested in Rochal Industries.
-
When was Rochal Industries acquired?
Rochal Industries was acquired on 19-Jul-2021.
-
Who acquired Rochal Industries?
Rochal Industries was acquired by Sanara MedTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
